The group's principle activities include licensing, developing and commercializing medical device technologies for the management of diabetes. The group operates from United States.
Executive Information
Name
Title
Email
Craig Misrach
Chmn., CEO, Pres.
N/A
Andreas Dreher
Dir.
N/A
Brent Cameron
Member - Advisory Board, Product Development Engineer